Background/Aims Crohn’s disease (CD) has a progressive nature and commonly perianal involvement. The aim of this study is to assess the prevalence, surgical treatment, and outcome of perianal fistulizing CD with associated risk factors in a large Chinese cohort.
Methods Hospitalized patients diagnosed with CD in our center were consecutively enrolled between January 2000 and December 2018. Transition of disease behavior was classified according to the presence or absence of penetrating behavior (B3 in the Montreal classification) at diagnosis and at a median follow-up of 102 months.
Results A total of 504 patients were included, of whom 207 (41.1%) were classified as B3 and 348 (69.0%) as L2/3 at follow-up. Transition of behavior to B3 was observed in 86 patients (17.1%). The incidence of perianal fistulizing lesions was 10.9% at 10 years with a final prevalence of 27.0% (n = 136) at the end of follow-up. Multivariate Cox regression identified independent risks of perianal fistulizing lesions for persistent B3 (hazard ratio, 4.72; 95% confidence interval, 1.91–11.66) and behavior transition of progressed to B3 (hazard ratio, 9.90; 95% confidence interval, 4.60–21.33). Perianal surgical treatments were performed in 104 patients (20.6%). Thirty-six cases (7.1%) were refractory, and it is independently associated with behavior of persistent B3 (P= 0.011).
Conclusions Perianal fistulizing lesions occurred frequently in Chinese CD patients. Its incidence and refractory outcome were closely associated with the penetrating CD behavior. An additional risk of perianal fistulizing lesions was indicated for CD patients with behavior of progressing to B3, suggesting further attention.
The role and efficacy of exclusive enteral nutrition (EEN) in the treatment of luminal Crohn’s disease (CD) has been well established over the last 2 decades. Consequently, in many centers nutritional therapy is now considered first line therapy in the induction of remission of active CD. However, the use of nutritional therapy in complicated CD has yet to be fully determined. This article aimed to review case reports and clinical trials published in the last decade that have considered and evaluated nutritional therapy in the setting of complicated CD in children and adults. Published literature focusing upon the use of nutritional therapy as part of medical therapy in the management of complicated CD were identified and reviewed. Although there continue to be various interventions utilized for complicated CD, the currently available literature demonstrates that nutritional therapies, especially EEN, have important roles in the management of these complex scenarios. Further assessments, involving large numbers of patients managed with consistent approaches, are required to further substantiate these roles.
Citations
Citations to this article as recorded by
Adjunct polymeric exclusive enteral nutrition helps achieve biochemical remission in active Crohn’s disease in adults irrespective of disease location and concomitant corticosteroid use Hellen Kuo, Katrina Tognolini, Rumbidzai Mutsekwa, Dheeraj Shukla, Laura Willmann, Hadi Moattar, Alexander Dorrington, Naveed Ishaq, Maneesha Bhullar, John Edwards, Waled Mohsen, Pradeep Kakkadasam Ramaswamy Frontline Gastroenterology.2025; 16(1): 3. CrossRef
Positionspapier der Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) zum zulassungsüberschreitenden Gebrauch von für Erwachsene mit CED zugelassenen Biologika und Signalinhibitoren bei Kindern und Jugendlichen Jan Däbritz, Martin Classen, Kathrin Krohn, Andreas Krahl, Stephan Buderus, Elke Lainka, Jan de Laffolie, Carsten Posovszky Zeitschrift für Gastroenterologie.2025; 63(03): 255. CrossRef
Understanding Role of Nutrition in Inflammatory Bowel Disease: A Comprehensive Review With Incorporation of AGA Update Galvin Dhaliwal, Dushyant Singh Dahiya, Ashvin Singh Dhaliwal, Hassam Ali, Manesh Kumar Gangwani, Fouad Jaber, Saqr Alsakarneh, Islam Mohamed, Umar Hayat, Bhanu Siva Mohan Pinnam, Sahib Singh, Sasha Mangray, Stephen Bickston Journal of Gastroenterology and Hepatology.2025;[Epub] CrossRef
Mycobacterium avium ssp. paratuberculosis and Crohn’s Disease—Diagnostic Microbiological Investigations Can Inform New Therapeutic Approaches John M. Aitken, Jack E. Aitken, Gaurav Agrawal Antibiotics.2024; 13(2): 158. CrossRef
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignass, Robert Ehehalt, Christoph-Thomas Germer, P. C. Grunert, Ulf Helwig, Karoline Horisberger, Klaus Herrlinger, Peter Kienle, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Zeitschrift für Gastroenterologie.2024; 62(08): 1229. CrossRef
Mechanisms of Action of Exclusive Enteral Nutrition and Other Nutritional Therapies in Crohn’s Disease Ramasatyaveni Geesala, Pratik Gongloor, Neeraja Recharla, Xuan-Zheng Shi Nutrients.2024; 16(21): 3581. CrossRef
Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis Aleksandra Jatkowska, Bernadette White, Konstantinos Gkikas, John Paul Seenan, Jonathan MacDonald, Konstantinos Gerasimidis Journal of Crohn's and Colitis.2024;[Epub] CrossRef
Is Salt at Fault? Dietary Salt Consumption and Inflammatory Bowel Disease Rebecca Kuang, Stephen J D O’Keefe, Claudia Ramos del Aguila de Rivers, Filippos Koutroumpakis, David G Binion Inflammatory Bowel Diseases.2023; 29(1): 140. CrossRef
The Role of the Gut Microbiota in the Relationship Between Diet and Human Health Bryce K. Perler, Elliot S. Friedman, Gary D. Wu Annual Review of Physiology.2023; 85(1): 449. CrossRef
Global research trends on diet and nutrition in Crohn’s disease Muna Shakhshir, Sa'ed H Zyoud World Journal of Gastroenterology.2023; 29(20): 3203. CrossRef
Enterale Ernährungstherapien beim pädiatrischen M.
Crohn Anwendungen und Wirkweise André Hörning, Anjona Schmidt-Choudhury Aktuelle Ernährungsmedizin.2023; 48(03): 183. CrossRef
Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter Nikolas Dovrolis, Anastasia Moschoviti, Smaragdi Fessatou, George Karamanolis, George Kolios, Maria Gazouli Biomedicines.2023; 11(7): 1979. CrossRef
Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases Hala Elzayat, Ghaidaa Mesto, Farah Al-Marzooq Nutrients.2023; 15(15): 3377. CrossRef
Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches Catherine O’Reilly, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, R. Paul Ross Microbiome Research Reports.2023;[Epub] CrossRef
Current understanding of the aetiology and pathogenesis of inflammatory bowel diseases (Part 2): the role of the microbiome and nutritional factors A. I. Khavkin, K. M. Nikolaychuk, E. V. Shrayner, D. R. Shaimardanova, A. S. Veremenko, I. D. Levchenko, P. Ya. Platonova, M. F. Novikova, V. V. Dudurich Experimental and Clinical Gastroenterology.2023; (12): 164. CrossRef
FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence Catarina D. Simões, Marta Maganinho, Ana S. Sousa European Journal of Nutrition.2022; 61(3): 1187. CrossRef
Effects of Olive Oil and Its Components on Intestinal Inflammation and Inflammatory Bowel Disease Josip Vrdoljak, Marko Kumric, Marino Vilovic, Dinko Martinovic, Iris Jeroncic Tomic, Mladen Krnic, Tina Ticinovic Kurir, Josko Bozic Nutrients.2022; 14(4): 757. CrossRef
Exclusive enteral nutrition: An optimal care pathway for use in children with active luminal Crohn's disease Deirdre Burgess, Kathleen H McGrath, Caitlin Watson, Tanya Collins, Stephanie Brown, Katie Marks, Kate Dehlsen, Kim Herbison, Emma Landorf, Laura Benn, Julia Fox, Ming Liew Journal of Paediatrics and Child Health.2022; 58(4): 572. CrossRef
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004 Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Oc Zeitschrift für Gastroenterologie.2022; 60(03): 332. CrossRef
The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos Journal of Clinical Medicine.2022; 11(11): 3045. CrossRef
Laser Therapy in Perianal Fistulas Mircea Sandor, Maur Sebastian Horgos, Ioan Lucian Borza, Rodica Negrean, Mihai Botea, Szuhai Erika Bimbo, Anca Huniadi, Liliana Sachelarie, Loredana Liliana Hurjui, Irina Mihaela Jemnoschi Hreniuc Applied Sciences.2022; 12(23): 12433. CrossRef
Enterale Ernährungstherapien beim pädiatrischen M. Crohn André Hörning, Anjona Schmidt-Choudhury Kinder- und Jugendmedizin.2022; 22(06): 439. CrossRef
Dietary patterns, beliefs and behaviours among individuals with inflammatory bowel disease: a cross‐sectional study K. J. Kamp, B. Pennings, D. Javelli, G. Wyatt, B. Given Journal of Human Nutrition and Dietetics.2021; 34(2): 257. CrossRef
Alterations in drug disposition in older adults: a focus on geriatric syndromes Dorsa Maher, Nagham Ailabouni, Arduino A. Mangoni, Michael D. Wiese, Emily Reeve Expert Opinion on Drug Metabolism & Toxicology.2021; 17(1): 41. CrossRef
Nutritional Therapy Strategies in Pediatric Crohn’s Disease Charlotte M. Verburgt, Mohammed Ghiboub, Marc A. Benninga, Wouter J. de Jonge, Johan E. Van Limbergen Nutrients.2021; 13(1): 212. CrossRef
Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice Fuzheng Tao, Xi Xing, Jiannong Wu, Ronglin Jiang, Tamil Selvan Anthonymuthu PLOS ONE.2021; 16(3): e0248482. CrossRef
Fish Sidestream-Derived Protein Hydrolysates Suppress DSS-Induced Colitis by Modulating Intestinal Inflammation in Mice Maria G. Daskalaki, Konstantinos Axarlis, Tone Aspevik, Michail Orfanakis, Ourania Kolliniati, Ioanna Lapi, Maria Tzardi, Eirini Dermitzaki, Maria Venihaki, Katerina Kousoulaki, Christos Tsatsanis Marine Drugs.2021; 19(6): 312. CrossRef
Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea Hyun Jin Kim, Seak Hee Oh, Sung Hee Lee, Yu-Bin Kim, Dae Yeon Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Kyung Mo Kim Gut and Liver.2021; 15(6): 851. CrossRef
The Effect of Formula-based Nutritional Treatment on Colitis in a Murine Model Sooyoung Jang, Younjuong Kim, Changjun Lee, Bomi Kwon, Jihye Noh, Jai J. Jee, Sang Sun Yoon, Hong Koh, Sowon Park Journal of Korean Medical Science.2021;[Epub] CrossRef
Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Luís Rodrigues, Sofia Moeda, Helena Loreto, Sara Azevedo, Inês Asseiceira, Catarina Maltez, Ana Fernandes, Ana Paula Mourato, Ana Isabel Lopes Nutrición Clínica y Dietética Hospitalaria.2021;[Epub] CrossRef